[go: up one dir, main page]

NO20026247L - 5-aminoalkyl-pyrazolo[4,3-d]pyrimidiner med en fosfodiesterase V-inhiberende virkning - Google Patents

5-aminoalkyl-pyrazolo[4,3-d]pyrimidiner med en fosfodiesterase V-inhiberende virkning

Info

Publication number
NO20026247L
NO20026247L NO20026247A NO20026247A NO20026247L NO 20026247 L NO20026247 L NO 20026247L NO 20026247 A NO20026247 A NO 20026247A NO 20026247 A NO20026247 A NO 20026247A NO 20026247 L NO20026247 L NO 20026247L
Authority
NO
Norway
Prior art keywords
pyrazolo
phosphodiesterase
pyrimidines
aminoalkyl
inhibitory effect
Prior art date
Application number
NO20026247A
Other languages
English (en)
Other versions
NO20026247D0 (no
Inventor
Rochus Jonas
Pierre Schelling
Maria Christadler
Norbert Beier
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of NO20026247D0 publication Critical patent/NO20026247D0/no
Publication of NO20026247L publication Critical patent/NO20026247L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20026247A 2000-06-29 2002-12-27 5-aminoalkyl-pyrazolo[4,3-d]pyrimidiner med en fosfodiesterase V-inhiberende virkning NO20026247L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10031584A DE10031584A1 (de) 2000-06-29 2000-06-29 5-Aminoalkyl-pyrazolo[4,3-d]pyrimidine
PCT/EP2001/007378 WO2002000660A1 (de) 2000-06-29 2001-06-28 5-aminoalkyl-pyrazolo[4,3-d]pyrimidine mit phosphodiesterase v inhibierender wirkung

Publications (2)

Publication Number Publication Date
NO20026247D0 NO20026247D0 (no) 2002-12-27
NO20026247L true NO20026247L (no) 2002-12-27

Family

ID=7647151

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20026247A NO20026247L (no) 2000-06-29 2002-12-27 5-aminoalkyl-pyrazolo[4,3-d]pyrimidiner med en fosfodiesterase V-inhiberende virkning

Country Status (21)

Country Link
US (1) US7060823B2 (no)
EP (1) EP1296986B1 (no)
JP (1) JP4964388B2 (no)
KR (1) KR20030017558A (no)
CN (1) CN1439011A (no)
AR (1) AR028772A1 (no)
AT (1) ATE519761T1 (no)
AU (2) AU2001279700B2 (no)
BR (1) BR0111915A (no)
CA (1) CA2410399C (no)
CZ (1) CZ20024054A3 (no)
DE (1) DE10031584A1 (no)
ES (1) ES2367704T3 (no)
HU (1) HUP0301587A3 (no)
MX (1) MXPA02012263A (no)
NO (1) NO20026247L (no)
PL (1) PL358551A1 (no)
RU (1) RU2271359C2 (no)
SK (1) SK17632002A3 (no)
WO (1) WO2002000660A1 (no)
ZA (1) ZA200209728B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19942474A1 (de) * 1999-09-06 2001-03-15 Merck Patent Gmbh Pyrazolo[4,3-d]pyrimidine
DE10031585A1 (de) * 2000-06-29 2002-01-10 Merck Patent Gmbh 2-Aminoalkyl-thieno[2,3-d]pyrimidine
DE10058662A1 (de) * 2000-11-25 2002-05-29 Merck Patent Gmbh Verwendung von Pyrazolo[4,3-d]pyrimidinen
AU2004234158B2 (en) 2003-04-29 2010-01-28 Pfizer Inc. 5,7-diaminopyrazolo[4,3-D]pyrimidines useful in the treatment of hypertension
CN100439371C (zh) * 2003-04-29 2008-12-03 辉瑞大药厂 可用于治疗高血压的5,7-二氨基吡唑并[4,3-d]嘧啶
US7572799B2 (en) * 2003-11-24 2009-08-11 Pfizer Inc Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors
GB0327319D0 (en) * 2003-11-24 2003-12-24 Pfizer Ltd Novel pharmaceuticals
GB0327323D0 (en) * 2003-11-24 2003-12-31 Pfizer Ltd Novel pharmaceuticals
JP2007532526A (ja) * 2004-04-07 2007-11-15 ファイザー・インク ピラゾロ［４，３−ｄ］ピリミジン類
CA2585557C (en) * 2004-10-28 2009-08-18 Pharmacia & Upjohn Company Llc Pyrazolo[4,3-d] pyrimidine derivatives useful as pde-5 inhibitors
PL1881985T3 (pl) * 2005-05-12 2011-05-31 Pfizer Bezwodne krystaliczne postacie N-[1-(2-etoksyetylo)-5-(N-etylo-N-metyloamino)-7-(4-metylopirydyn-2-yloamino)-1H-pirazolo[4,3-d]pirymidyno-3-karbonylo]metano-sulfonoamidu
NL2000291C2 (nl) 2005-11-10 2009-02-17 Pfizer Prod Inc 1-(1-(2-ethoxyethyl)-3-ethyl-7-(4-methylpyridin-2-ylamino)-1H- pyrazool(4,3-d)pyrimidine-5-yl)piperidine-4-carbonzuur en zouten daarvan.
DE102012200360A1 (de) * 2012-01-11 2013-07-11 Bayer Intellectual Property Gmbh Substituierte Triazine und ihre Verwendung
CA2782774A1 (en) * 2012-07-06 2014-01-06 Pharmascience Inc. Protein kinase inhibitors

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075310A (en) * 1988-07-01 1991-12-24 Smith Kline & French Laboratories, Ltd. Pyrimidone derivatives as bronchodilators
JP2657760B2 (ja) * 1992-07-15 1997-09-24 小野薬品工業株式会社 ４−アミノキナゾリン誘導体およびそれを含有する医薬品
GB9311920D0 (en) 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
GB9423911D0 (en) 1994-11-26 1995-01-11 Pfizer Ltd Therapeutic agents
US5869486A (en) * 1995-02-24 1999-02-09 Ono Pharmaceutical Co., Ltd. Fused pyrimidines and pyriazines as pharmaceutical compounds
DE19644228A1 (de) * 1996-10-24 1998-04-30 Merck Patent Gmbh Thienopyrimidine
DE19752952A1 (de) * 1997-11-28 1999-06-02 Merck Patent Gmbh Thienopyrimidine
DE19942474A1 (de) 1999-09-06 2001-03-15 Merck Patent Gmbh Pyrazolo[4,3-d]pyrimidine

Also Published As

Publication number Publication date
AR028772A1 (es) 2003-05-21
HUP0301587A3 (en) 2005-11-28
CN1439011A (zh) 2003-08-27
EP1296986B1 (de) 2011-08-10
US20040029900A1 (en) 2004-02-12
NO20026247D0 (no) 2002-12-27
RU2271359C2 (ru) 2006-03-10
ES2367704T3 (es) 2011-11-07
WO2002000660A1 (de) 2002-01-03
JP4964388B2 (ja) 2012-06-27
MXPA02012263A (es) 2003-04-25
CA2410399C (en) 2010-02-16
PL358551A1 (en) 2004-08-09
AU2001279700B2 (en) 2006-08-24
JP2004501921A (ja) 2004-01-22
ATE519761T1 (de) 2011-08-15
CA2410399A1 (en) 2002-01-03
BR0111915A (pt) 2003-05-13
SK17632002A3 (sk) 2003-05-02
ZA200209728B (en) 2004-03-12
DE10031584A1 (de) 2002-01-10
CZ20024054A3 (cs) 2003-04-16
KR20030017558A (ko) 2003-03-03
US7060823B2 (en) 2006-06-13
EP1296986A1 (de) 2003-04-02
HUP0301587A2 (hu) 2003-09-29
AU7970001A (en) 2002-01-08

Similar Documents

Publication Publication Date Title
DK1416935T3 (da) 4-Amino-6-phenyl-pyrrolo[2,3-d]pyrimidinderivater
MA26881A1 (fr) 5-alkyl-pyrido [2,3-d]pyrimidines inhibitrices de tyrosine-kinases.
NO20021694D0 (no) Pyrazolo[4,3-d]pyrimidinderivater
IS8406A (is) 5,7-díamínópýrasóló [4,3-d] pýrimidín með PDE-5 hindrandi virkni
EE05351B1 (et) Prrolo[2,3-d]primidiinhendid
HK1054940A1 (en) Pyrimidine derivatives
DK0945443T3 (da) HIV-hæmmende pyrimidinderivater
DZ3266A1 (fr) Pyrido[2,3-d]pyrimidine-2,7-diamine inhibiteurs de kinase
AU1041802A (en) Tetrahydro-heterocycloazepinyl pyrimidine derivatives
NO20026247L (no) 5-aminoalkyl-pyrazolo[4,3-d]pyrimidiner med en fosfodiesterase V-inhiberende virkning
DK1210349T3 (da) Pyrazolo[4,3-d]pyrimidiner
AU2001279700A1 (en) 5-aminoalkyl-pyrazolo(4,3-d)pyrimidines with a phosphodiesterase v-inhibiting effect
IL155705A0 (en) Pyrimidine derivatives
DE50103649D1 (de) 2-aminoalkyl-thieno[2,3-d]pyrimidine
MXPA03000504A (es) Derivados de pirimidina.
NO20031412L (no) Substituerte 3,4-dihydro-pyrido[1,2-A]pyrimidiner
DK1326866T3 (da) Substituerede 3,4-dihydro-pyrido[1,2-a]pyrimidiner
SI1303496T1 (sl) Pirimidinski derivati

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application